元大金控元大金控 元大金控元大金控 元大金控元大金控

繁 简 EN
重大訊息 重大讯息 Announcements
返回上一頁 返回上一页 Back
檔案下載 档案下载 Download 09/25/2018
Yuanta FHC announces Yuanta Life's acquisition of Yuanta Asia Growth Investment, L.P. by private placement
  1. Name and nature of the subject matter (if preferred shares,the terms and conditions of issuance shall also be indicated,e.g.dividend yield): Yuanta Asia Growth Investment, L.P., a private equity fund
  2. Date of occurrence of the event: 2018/09/25
  3. Volume, unit price, and total monetary amount of the transaction:
    Volume: N/A(due to the nature of private equity fund)
  4. Counterpart to the trade and its relationship to the Company(if the trading counterpart is a natural person and furthermore is not an actual related party of the Company, the name of the trading counterpart is not required to be disclosed):
    Counterparty: Yuanta Asia Investment Limited
    Relationship: A related party of the company
  5. Where the counterpart to the trade is an actual related party,a public announcement shall also be made of the reason for choosing the related party as trading counterpart and the identity of the previous owner (including its relationship with the company and the trading counterpart), price of transfer, and date of acquisition:
    (1)The reason for choosing the related party as trading counterpart: The product design is unique.The investment team is experienced with proven track records and able to leverage the international networks of the financial holding company.
    (2)The previous owner party: N/A
  6. Where a person who owned the property within the past five years has been an actual related person of the company, a public announcement shall also include the dates and prices of acquisition and disposal by the related person and the person’s relationship to the company at those times: N/A
  7. Matters related to the creditor's rights currently being disposed of (including types of collateral of the disposed creditor's rights; if the creditor's rights are creditor's rights toward a related  person, the name of the related person and the book amount of the creditor's rights toward such related person currently being disposed of must also be announced): N/A
  8. Anticipated profit or loss from the disposal (not applicable in cases of acquisition of securities) (where originally deferred, the status or recognition shall be stated and explained): N/A
  9. Terms of delivery or payment (including payment period and monetary amount), restrictive covenants in the contract, and other important stipulations:
    The first contribution will be 25% of the total investment amount
    The rest of capital contributions are made upon each capital call notices According to Limited Partnership Agreement
  10. The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making department:
    The manner: commit to the private equity fund
    The reference basis : N/A(due to the nature of private equity fund)
    The decision making department: the investment is authorized by the board of directors
  11. Net worth per share of company underlying securities acquired or disposed of: N/A
  12. The discrepancy between the reference price of private placement and the transaction amount per share is 20 percent or more of the transaction amount: N/A
  13. Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g.pledges):
    Cumulative volume: N/A(due to the nature of private equity fund)
    Cumulative amount: USD10,000,000
    Percentage: 10% of expected total fund-raising USD100,000,000
    Status of any restriction of right: N/A
  14. Current ratio of private placement of securities (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operating capital as shown in the most recent financial statement:
    Ratio to the total assets: 0.51%
    Ratio to shareholder's equity: 0.62%
    Operating Capital: N/A
  15. Broker and broker's fee: N/A
  16. Concrete purpose or use of the acquisition or disposition: Legal use of the insurance funds
  17. Do the directors have any objection to the present transaction?: No
  18. The trading counterparty is a related party: Yes
  19. Approval date by board of directors:2018/09/25
  20. Recognition date by supervisors or submission date by audit committee: 2018/09/18
  21. Has the CPA issued an opinion on the unreasonableness of the price of the current transaction?: No
  22. Any other matters that need to be specified: Due to the adjustment of terms and conditions of the fund, the resolution of the board on 2018/07/31 was revised. The revision will be proceeded, following the approval of the revised resolution.